Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Inventory Average (2016 - 2025)

Historic Inventory Average for Heron Therapeutics (HRTX) over the last 10 years, with Q3 2025 value amounting to $71.5 million.

  • Heron Therapeutics' Inventory Average rose 6099.94% to $71.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.5 million, marking a year-over-year increase of 6099.94%. This contributed to the annual value of $47.6 million for FY2024, which is 146.15% down from last year.
  • As of Q3 2025, Heron Therapeutics' Inventory Average stood at $71.5 million, which was up 6099.94% from $64.9 million recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Inventory Average registered a high of $71.5 million during Q3 2025, and its lowest value of $21.1 million during Q1 2024.
  • In the last 5 years, Heron Therapeutics' Inventory Average had a median value of $48.3 million in 2023 and averaged $47.8 million.
  • As far as peak fluctuations go, Heron Therapeutics' Inventory Average tumbled by 6041.53% in 2024, and later soared by 20233.92% in 2025.
  • Over the past 5 years, Heron Therapeutics' Inventory Average (Quarter) stood at $44.9 million in 2021, then rose by 18.83% to $53.4 million in 2022, then decreased by 21.25% to $42.1 million in 2023, then grew by 17.82% to $49.6 million in 2024, then soared by 44.27% to $71.5 million in 2025.
  • Its last three reported values are $71.5 million in Q3 2025, $64.9 million for Q2 2025, and $55.0 million during Q1 2025.